Fig. 2
From: Childhood resolution of early abnormal miRNA following neonatal encephalopathy
Changes in microRNA expression in response to LPS treatment in NE and controls. (a-d) Graphs show relative (ΔCT) expression of miR-20a (a), miR-20b (b), miR-93 (c) and miR-532 (d) in the serum of child control (n = 7–11), Neonate NE (n = 9–10) and Child NE (n = 6–11). Whole blood from both groups was stimulated with Lipopolysaccharides (LPS, 10 ng/mL) for 1 h at 37 °C, and serum separated at 900 g for 10 min. “veh” refers to unstimulated (PBS) and it is represented in light colours. Dark colour samples are the corresponding LPS-treated samples. Comparisons were done between three independent cohorts using Kruskal-Wallis test and expressed as ΔCT expression with median and interquartile range (IQR). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Children control (blue), Neonates NE (orange) and children NE (purple).
